Sofinnova Investments related stories
All articles and analysis
peHUB Wire: Monday, Octoober 19, 2009Random Ramblings
- peHUB Wire: Monday, Octoober 19, 2009
Random Ramblings
- peHUB Wire: Wednesday, October 14, 2009
Random Ramblings
- peHUB Wire: Wednesday, October 14, 2009
Random Ramblings
- Top VC Recipients of 2009 (so far)
In light of Twitter having raised over $135 million in VC funding so far this year (new round plus January round), I figured it was time for a Top 10 list of 2009 venture recipients. And, no, Twitter is not in the top spot. That honor goes to Clovis Oncology, which raised over $146 million in a Series A round four months ago. A few metrics notes: (1) The list only includes U.S.-based companies. It didn't appear that any non-U.S. companies qualified and, if they did, I didn't want to get bogged down in currency disputes; (2) The list aggregates all VC funding secured in 2009, rather than individual rounds; (3) The calculations do not include government funding (grants, etc); (4) The ability to secure lots of VC dollars does not necessarily correlate to a strong company or strong returns. So, without further ado, get the full list after the jump...
- Alvine Pharma Raises $21.5 Million
Alvine Pharmaceuticals Inc., a San Carlos, Calif.-based developer of therapeutics for autoimmune and gastrointestinal diseases, has raised $21.5 million in additional Series A funding. The round now stands at around $47.5 million. Panorama Capital led the expansion tranche, and was joined by return backers InterWest Partners, Prospect Venture Partners, Sofinnova Ventures, Black River Asset Management and Flagship Ventures.
- peHUB Wire: Tuesday, September 15, 2009
Competitive Landscape